Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City-Reference-Cited by-同舟云学术

Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City

Published:2020-11-03 Issue:7844 Volume:590 Page:146-150
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Stadlbauer Daniel^ORCID,Tan Jessica^ORCID,Jiang Kaijun,Hernandez Matthew M.^ORCID,Fabre Shelcie,Amanat Fatima^ORCID,Teo Catherine,Arunkumar Guha Asthagiri^ORCID,McMahon Meagan,Capuano Christina,Twyman Kathryn^ORCID,Jhang Jeffrey,Nowak Michael D.,Simon Viviana,Sordillo Emilia Mia^ORCID,van Bakel Harm^ORCID,Krammer Florian^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-020-2912-6.pdf

Reference20 articles.

1. Gonzalez-Reiche, A. S. et al. Introductions and early spread of SARS-CoV-2 in the New York City area. Science 369, 297–301 (2020).

2. Huang, A. T. et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat. Commun. 11, 4704 (2020).

3. Chandrashekar, A. et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science 369, 812–817 (2020).

4. Randolph, H. E. & Barreiro, L. B. Herd immunity: understanding COVID-19. Immunity 52, 737–741 (2020).

5. Krammer, F. & Simon, V. Serology assays to manage COVID-19. Science 368, 1060–1061 (2020).

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disentangling the relationship between cancer mortality and COVID-19 in the US;eLife;2024-08-27

2. Disentangling the relationship between cancer mortality and COVID-19 in the US;eLife;2024-08-27

3. Disentangling the relationship between cancer mortality and COVID-19 in the US;2024-07-16

4. SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023;Nature Communications;2024-07-11

5. Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer;Vaccines;2024-06-26